Radialis Garners FDA 510(k) Clearance for Portable PET Device
Offering images of high spatial resolution and a small system footprint, the new positron emission tomography (PET) modality from Radialis may facilitate enhanced imaging of emerging radiotracer agents and key biomarkers in targeted organs.
The Food and Drug Administration (FDA) has granted 510(k) clearance to the Radialis PET Imager, an emerging portable complement to traditional positron emission tomography/computed tomography (PET/CT) systems.
Specially designed for organ-targeted, close-range imaging, the Radialis PET Imager reportedly has increased sensitivity to radiotracer imaging agents, according to Radialis, the manufacturer of the device.
The company said the device combines a partial-ring plantar PET camera and lutetium-containing gamma ray detectors. The Radialis PET Imager can visualize any injected positron-emitting radiotracer agent and provide images of high spatial resolution, noted Radialis.
Radialis said the device also has two plantar detectors that can be adjusted as necessary to allow a variety of scans and adaptability to patients who are lying down, standing, or sitting. The portability of the 4.5 feet high device also facilitates smoother incorporation into existing nuclear medicine facilities, according to Radialis.
Where Things Stand with the Radiologist Shortage
June 18th 2025A new report conveys the cumulative impact of ongoing challenges with radiologist residency positions, reimbursement, post-COVID-19 attrition rates and the aging of the population upon the persistent shortage of radiologists in the United States.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Possible Real-Time Adaptive Approach to Breast MRI Suggests ‘New Era’ of AI-Directed MRI
June 3rd 2025Assessing the simulated use of AI-generated suspicion scores for determining whether one should continue with full MRI or shift to an abbreviated MRI, the authors of a new study noted comparable sensitivity, specificity, and positive predictive value for biopsies between the MRI approaches.
